|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.40 EUR | -3.09% |
|
+1.41% | -16.61% |
| 01-14 | Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle |  |
| 01-14 | Stifel Sees Nearly 37% Upside Potential for Abivax | |
| Capitalization | 8.06B 9.36B 7.51B 6.99B 13.01B 846B 13.95B 86.34B 33.97B 404B 35.1B 34.38B 1,483B | P/E ratio 2025 * |
-37.2x | P/E ratio 2026 * | -36.8x |
|---|---|---|---|---|---|
| Enterprise value | 7.52B 8.74B 7.01B 6.52B 12.14B 789B 13.02B 80.57B 31.7B 377B 32.75B 32.08B 1,384B | EV / Sales 2025 * |
948x | EV / Sales 2026 * | 209x |
| Free-Float |
90.83% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Abivax
More recommendations
More press releases
| 1 day | -3.09% | ||
| 1 week | +1.41% | ||
| Current month | -16.61% | ||
| 1 month | +6.70% | ||
| 3 months | +23.80% | ||
| 6 months | +1,093.82% | ||
| Current year | -16.61% |
| 1 week | 100.2 |  | 132 |
| 1 month | 93.9 | | 132 |
| Current year | 94.2 | | 132 |
| 1 year | 4.51 | | 132 |
| 3 years | 4.51 | | 132 |
| 5 years | 4.51 | | 132 |
| 10 years | 3.87 | | 132 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 04/05/2023 | |
Didier Blondel
DFI | Director of Finance/CFO | - | 01/01/2017 |
Fabio Cataldi
CTO | Chief Tech/Sci/R&D Officer | 59 | 14/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 15/08/2022 | |
Kinam Hong
BRD | Director/Board Member | - | - |
| Chairman | 67 | 04/05/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.09% | +1.41% | +1,545.90% | +1,336.34% | 9.36B | |
| -0.62% | +1.37% | +2.45% | +11.75% | 49.36B | |
| -0.03% | -0.79% | +23.04% | +8.62% | 41.09B | |
| -2.44% | +5.59% | +67.70% | +24.99% | 37.43B | |
| -0.47% | -1.17% | +21.15% | +36.02% | 31.37B | |
| +1.69% | +14.79% | +208.48% | +309.67% | 23.83B | |
| -14.53% | -27.43% | +23,494.98% | +3,721.51% | 14.86B | |
| +0.26% | +3.00% | +84.36% | +170.41% | 17.41B | |
| -0.47% | +4.10% | +54.27% | +11.12% | 14.86B | |
| -1.20% | -3.01% | -8.48% | -18.68% | 13.94B | |
| Average | -0.91% | +0.10% | +2,549.39% | +561.17% | 25.35B | |
| Weighted average by Cap. | -0.73% | +1.05% | +1,479.52% | +319.80% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.74M 6.66M 5.35M 4.97M 9.25M 602M 9.92M 61.41M 24.17M 288M 24.97M 24.46M 1.06B | 35.83M 41.6M 33.39M 31.07M 57.8M 3.76B 62M 384M 151M 1.8B 156M 153M 6.59B |
| Net income | -263M -305M -245M -228M -424M -27.58B -455M -2.82B -1.11B -13.19B -1.14B -1.12B -48.38B | -193M -224M -180M -167M -311M -20.24B -334M -2.07B -813M -9.68B -840M -823M -35.5B |
| Net Debt | -539M -626M -502M -467M -869M -56.52B -932M -5.77B -2.27B -27.02B -2.35B -2.3B -99.12B | -542M -629M -505M -470M -874M -56.85B -938M -5.8B -2.28B -27.18B -2.36B -2.31B -99.71B |
More financial data
* Estimated data
Employees
67
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 100.40 € | -3.09% | 64,336 |
| 15/01/26 | 103.60 € | -4.07% | 346,515 |
| 14/01/26 | 108.00 € | +3.85% | 237,953 |
| 13/01/26 | 104.00 € | 0.00% | 216,864 |
| 12/01/26 | 104.00 € | +5.05% | 798,100 |
Real-time Euronext Paris, January 16, 2026 at 01:34 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
103.60EUR
Average target price
97.03EUR
Spread / Average Target
-6.34%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABVX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition